Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS

CONCLUSION: Cardio-metabolic risk is similar in all phenotypes of PCOS despite differences in anthropometry and AMH levels. All women diagnosed with PCOS should undergo screening and lifelong surveillance for MS, IR and cardiovascular diseases, irrespective of clinical phenotype or AMH level. This needs further validation in prospective multi-center studies across the country, with larger sample sizes and adequate power.PMID:37328054 | DOI:10.1016/j.ando.2023.06.001
Source: Annales d'Endocrinologie - Category: Endocrinology Authors: Source Type: research